Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer
PARP inhibitors have been widely tested in clinical trials, especially for the treatment of breast cancer and ovarian cancer, and were shown to be highly successful. Because PARP primarily functions in sensing and repairing DNA strand breaks, the therapeutic effect of PARP inhibition is generally be...
Main Authors: | Dong Hou, Zhaojian Liu, Xiuhua Xu, Qiao Liu, Xiyu Zhang, Beihua Kong, Jian-Jun Wei, Yaoqin Gong, Changshun Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231718301897 |
Similar Items
-
Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells
by: Limei Xu, et al.
Published: (2020-09-01) -
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
by: Liya Ding, et al.
Published: (2018-12-01) -
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
by: Hanlin Ma, et al.
Published: (2022-03-01) -
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2
by: Shourong Wang, et al.
Published: (2021-03-01) -
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12
by: Zixiang Wang, et al.
Published: (2022-10-01)